Clinical Trial Update: Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for sintilimab maintenance therapy in patients with extensive small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Sintlimab (sintilimab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Small Cell Lung Cancer, Extensive Disease | Phase 2 | Status: UNKNOWN